正在加载视频...
视频加载失败
Modern science can prove biosimilars are equivalent without costly, outdated, unnecessary clinical studies. My bill pushed the FDA to follow the evidence—and now they have. This reform cuts costs, not corners. Thanks to Dr. Marty Makary for his leadership in making this reform a reality.
0 条评论
暂无评论
原始帖子的评论将显示在这里
